Varicose veins: Loss of release of vascular endothelial growth factor and reduced plasma nitric oxide

European Journal of Vascular and Endovascular Surgery

Volumn 22, Issue 6, 2001, Pages 551-556

  Hollingsworth, S J ^a   Tang, C B ^a   Dialynas, M ^a   Barker, S G E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Nitric oxide; Varicose veins; Vascular endothelial growth factor

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; NITRIC OXIDE;

ADULT; AGED; ARM; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CUFF; FEMALE; FOOT; HUMAN; KNEE; MALE; PRIORITY JOURNAL; REST; STATISTICAL ANALYSIS; SUPINE POSITION; VARICOSIS; VENOUS STASIS;

EID: 0035663231     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1520     Document Type: Article

References (25)

1. Neutrophil activation in experimental ambulatory venous hypertension
2. The aetiology and treatment of varicose ulcers of the leg
3. The role of arteriovenous shunts in venous disease
4. The effect of venous hypertension on the microcirculation
5. Perfused human saphenous veins for the study of the origin of varicose veins: Role of the endothelium and of hypoxia
6. Interactions between endothelial cells and smooth muscle cells after their activation by hypoxia. A possible etiology for venous disease
7. Endothelial permeability and IL-6 production, during hypoxia: Role of ROS in signal transduction
8. Systemic hypoxia promotes leukocyte-endothelial adherence via reactive oxidant generation
9. Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes
10. Macrophages responses to hypoxia: Relevance to disease mechanisms
11. Effects of vasoactive agents in healthy and diseased human saphenous vein
12. Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis
13. Characterization of endothelin receptors in human varicose veins
14. In vitro evaluation of endothelial and smooth muscle function of primary varicose veins
15. Plasma endothelin-1 release in normal and varicose saphenous veins
16. VEGF modulates NO production: The basis of a cytoprotective effect?
17. Vascular endothelial growth factor, a potent and selective angiogenic agent
18. Antioxidants and the bioactivity of endothelium-derived nitric oxide
19. The varicose saphenous vein, functional and ultrastructural studies, with special reference to smooth muscle
20. Biochemical and histological analysis of collagen and elastin content and smooth muscle density in normal and varicose veins
21. Some thoughts on the aetiology of varicose veins
22. Histopathological studies of the valves of varicose veins
23. Reactions of venous smooth muscle in normal men and patients with varicose veins
24. Increased plasma vascular endothelial growth factor among patients with chronic venous disease